Literature DB >> 8491405

GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis.

M H Davies1, E Elias, S Acharya, W Cotton, G C Faulder, A A Fryer, R C Strange.   

Abstract

Studies were carried out to test the hypothesis that the GSTM1 null phenotype at the mu (mu) class glutathione S-transferase 1 locus is associated with an increased predisposition to primary biliary cirrhosis. Starch gel electrophoresis was used to compare the prevalence of GSTM1 null phenotype 0 in patients with end stage primary biliary cirrhosis and a group of controls without evidence of liver disease. The prevalence of GSTM1 null phenotype in the primary biliary cirrhosis and control groups was similar; 39% and 45% respectively. In the primary biliary cirrhosis group all subjects were of the common GSTM1 0, GSTM1 A, GSTM1 B or GSTM1 A, B phenotypes while in the controls, one subject showed an isoform with an anodal mobility compatible with it being a product of the putative GSTM1*3 allele. As the GSTM1 phenotype might be changed by the disease process, the polymerase chain reaction was used to amplify the exon 4-exon 5 region of GSTM1 and show that in 13 control subjects and 11 patients with primary biliary cirrhosis, GSTM1 positive and negative genotypes were associated with corresponding GSTM1 expressing and non-expressing phenotypes respectively. The control subject with GSTM1 3 phenotype showed a positive genotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491405      PMCID: PMC1374319          DOI: 10.1136/gut.34.4.549

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

4.  [Hepatitis during treatment with tienilic acid (author's transl)].

Authors:  O Bousquet; T Saigot; P Bernard; J L Gerbal; A Sarrazin
Journal:  Therapie       Date:  1980 Mar-Apr       Impact factor: 2.070

5.  The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytoma brain.

Authors:  R C Strange; A A Fryer; B Matharoo; L Zhao; J Broome; D A Campbell; P Jones; I C Pastor; R V Singh
Journal:  Biochim Biophys Acta       Date:  1992-07-07

6.  The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes.

Authors:  R C Strange; C G Faulder; B A Davis; R Hume; J A Brown; W Cotton; D A Hopkinson
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

7.  Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties.

Authors:  B Mannervik; P Alin; C Guthenberg; H Jensson; M K Tahir; M Warholm; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.

Authors:  A B Olomu; C R Vickers; R H Waring; D Clements; C Babbs; T W Warnes; E Elias
Journal:  N Engl J Med       Date:  1988-04-28       Impact factor: 91.245

9.  Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importance.

Authors:  S Harada; M Abei; N Tanaka; D P Agarwal; H W Goedde
Journal:  Hum Genet       Date:  1987-04       Impact factor: 4.132

10.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Authors:  F J Gonzalez; R C Skoda; S Kimura; M Umeno; U M Zanger; D W Nebert; H V Gelboin; J P Hardwick; U A Meyer
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

View more
  13 in total

1.  Glutathione-S-Transferase M1 null genotype in autoimmune hepatitis.

Authors:  N K Fukagawa; P Liang; M Li; T Ashikaga; K R Reddy; E L Krawitt
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus.

Authors:  A A Fryer; L Zhao; J Alldersea; W R Pearson; R C Strange
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

3.  Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin.

Authors:  A W Harris; P A Gummett; J J Misiewicz; J H Baron
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

4.  Antioxidant status and GST gene polymorphisms in antitubercular treatment-induced hepatotoxicity patients.

Authors:  S V Rana; J K Kamboj; S K Sharma; R P Ola; S K Sinha; K Singh
Journal:  Hepatol Int       Date:  2013-07-18       Impact factor: 6.047

5.  High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.

Authors:  M Moshkowitz; F M Konikoff; Y Peled; M Santo; A Hallak; Y Bujanover; E Tiomny; T Gilat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori.

Authors:  J C Atherton; N Washington; P E Blackshaw; J L Greaves; A C Perkins; C J Hawkey; R C Spiller
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype.

Authors:  Aimee Hoskins; Sara Reiss; Pingsheng Wu; Ning Chen; Wei Han; Rui-hong Do; Rasul Abdolrasulnia; Ryszard Dworski
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

8.  GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis.

Authors:  Shahrokh Mohammadzadeh Ghobadloo; Bahram Yaghmaei; Valery Bakayev; Hossein Goudarzi; Babak Noorinayer; Farhad Haghighi Rad; Saeed Samiy; Sohrab Aghabozorghi; Mohammad Reza Zali
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

9.  Mycobacterial granulomatous inflammation in the ulcerated caecum of indomethacin-treated rats.

Authors:  A Anthony; A P Dhillon; H Fidler; J McFadden; O Billington; G Nygard; R E Pounder; A J Wakefield
Journal:  Int J Exp Pathol       Date:  1995-04       Impact factor: 1.925

10.  Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays.

Authors:  A H Walker; D Najarian; D L White; J F Jaffe; P A Kanetsky; T R Rebbeck
Journal:  Environ Health Perspect       Date:  1999-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.